Picture of Bioqual logo

BIOQ Bioqual Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Momentum

Relative Strength (%)
1m-8.5%
3m-9.64%
6m+4.48%
1yr-18.92%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-34.56%
50d MA-14.33%
200d MA-1.7%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital11.47%
Return on Equity14.24%
Operating Margin9.84%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st May 202331st May 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Bioqual EPS forecast chart

Profile Summary

Bioqual, Inc. is engaged in performing contract research services, which is primarily focused on animal models of human diseases, including acquired immune deficiency syndrome (AIDS), influenza, Respiratory Syncytial Virus (RSV) infection, Coronavirus infections (including COVID-19), Flavivirus infections (including Zika and Dengue), malaria, hepatitis, cancer, and other emerging infectious diseases. The Company also performs in vitro contract research services. It is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. The In vitro services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation and other cell-based assays. The Company provides its services to the federal government, universities and the life science and pharmaceutical industries.

Directors

Last Annual
May 31st, 2022
Last Interim
August 31st, 2022
Incorporated
January 5th, 1982
Public Since
July 14th, 1983
No. of Employees
108
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
894,416

BIOQ Share Price Performance

Upcoming Events for BIOQ

Q2 2023 Bioqual Inc Earnings Release

Q3 2023 Bioqual Inc Earnings Release

Similar to BIOQ

Picture of Acura Pharmaceuticals logo

Acura Pharmaceuticals

us flag iconPink Sheets on Nasdaq

Picture of Adhera Therapeutics logo

Adhera Therapeutics

us flag iconPink Sheets on Nasdaq

Picture of Advantis logo

Advantis

us flag iconPink Sheets on Nasdaq

Picture of Advaxis logo

Advaxis

us flag iconPink Sheets on Nasdaq

Picture of Adynxx logo

Adynxx

us flag iconPink Sheets on Nasdaq

FAQ

Or unlock with your email

Or unlock with your email